GreenTechMedia’s Michael Kanellos — Celebrating Gevo’s IPO

That day, Michael’s cause for celebration was Gevo, the biotech darling of Khosla Ventures and the Virgin Green Fund. Gevo’s unique technology causes microbes to secrete a form of isobutanol, but the company currently garners most of its revenue from corn ethanol.
“Craig, did you see Gevo? We had another IPO yesterday.” Michael smiled.
“No, I missed that. How did it do?” I asked.
“Rose from an opening price of $15 to $16.43 on the first day of trading. That moderate increase could be a good sign.”
“Whatever you say, man. I don’t know anyone in this arena whose opinions are of greater validity than yours.”
In the coming months, I’ll be doing a bit of writing for GreenTechMedia, contributing an article or two here and there. My goal, needless to say, is to bring as much information to the game – and enthusiasm — as Michael.
